Katherine Warren, MD

Katherine Warren, MD

Pediatric Hematology & Oncology Bethesda, MD

Physician


Office Address

  • National Cancer Institute
    Bldg 10 Crc, Rm 1-5750
    Bethesda, MD 20892
    Phone: (301) 435-4683
    Fax: (301) 480-2308

Are you Dr. Warren?

Claim your profile and join over 50% of U.S. physicians already on Doximity.

Claim this pageNo, this isn't me

Katherine Warren, MD

Pediatric Hematology & Oncology Bethesda, MD

Physician

13 Colleague InvitesIs this you? Register Now to see 13 messages.

Summary

  • Dr. Katherine Warren, MD is a board certified pediatric hematologist/oncologist in Bethesda, Maryland. She is currently licensed to practice medicine in Maryland.

Clinical Specialties & Interests

  • Pediatric Hematology & Oncology: General Pediatric Hematology & Oncology

Education & Medical Training

  • Children's National Medical Center/George Washington UniversityChildren's National Medical Center/George Washington University
  • National Capital ConsortiumNational Capital Consortium
  • Tufts University School of MedicineTufts University School of Medicine

Certifications & Licensure

  • MD State Medical LicenseMD State Medical License1993 - 2015
  • American Board of PediatricsPediatrics
  • American Board of PediatricsPediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Establishment Of An International Dipg RegistryNational Cancer Institute
    2011 - 2011
  • Imaging As A Biomarker For Diffuse Intrinsic Brainstem GliomasNational Cancer Institute
    2010 - 2011
  • Phase II Trial Of O6-Benzylguanine And Temozolomide In Pediatric Patients With HNational Cancer Institute
    2010 - 2011
  • PH I Radiation And Lenalidomide In Pediatric Malignant GliomaNational Cancer Institute
    2010 - 2011
  • Noninvasive Evaluation Of Pediatric CNS TumorsNational Cancer Institute
    2010 - 2011
  • Phase II Trial Of Peg-Intron In Children With Diffuse Pontine GliomasNational Cancer Institute
    2010 - 2011
  • Preclinical Development Of New Therapeutics For Children With CNS TumorsNational Cancer Institute
    2010 - 2011
  • Diffuse Intrinsic Pontine Glioma Genomic StudyNational Cancer Institute
    2010 - 2011
  • Differential Gene Expression And Targeting Of Gliomas Using RadiationNational Cancer Institute
    2010 - 2011
  • A Phase I Trial Of CC-5013 (LENALIDOMIDE) In Pediatric Patients With Recurrent ONational Cancer Institute
    2010 - 2010
  • An Exploratory Study Of Biologic And Pathophysiologic Efects Of Radiation TherapNational Cancer Institute
    2010 - 2011
  • Convection Enhanced Delivery Of Agents Into The Brainstem Of Patients With DIFFNational Cancer Institute
    2010 - 2011
  • Phase II Trial Of Peg-Intron In Children With Diffuse Pontine GliomasDivision Of Basic Sciences - Nci
    2009 - 2009
  • Phase II Trial Of O6-Benzylguanine And Temozolomide In Pediatric Patients WithDivision Of Basic Sciences - Nci
    2009 - 2009
  • Imaging As A Biomarker For Diffuse Intrinsic Brainstem GliomasDivision Of Basic Sciences - Nci
    2009 - 2009
  • Diffuse Intrinsic Pontine Glioma Genomic StudyDivision Of Basic Sciences - Nci
    2009 - 2009
  • Differential Gene Expression And Targeting Of Gliomas Using RadiationDivision Of Basic Sciences - Nci
    2009 - 2009
  • Convection Enhanced Delivery Of Agents Into The Brainstem Of Patients With DIFFDivision Of Basic Sciences - Nci
    2009 - 2009
  • An Exploratory Study Of Biologic And Pathophysiologic Efects Of Radiation TherapDivision Of Basic Sciences - Nci
    2009 - 2009
  • A Phase I Trial Of CC-5013 (LENALIDOMIDE) In Pediatric Patients With Recurrent ODivision Of Basic Sciences - Nci
    2009 - 2009
  • Imaging As A Biomarker For Diffuse Intrinsic Brainstem GliomasNational Cancer Institute
    2008 - 2008
  • Diffuse Intrinsic Pontine Glioma Genomic StudyNational Cancer Institute
    2008 - 2008
  • Differential Gene Expression And Targeting Of Gliomas Using RadiationNational Cancer Institute
    2008 - 2008
  • Phase II Trial Of O6-Benzylguanine And Temozolomide In Pediatric Patients WithNational Cancer Institute
    2008 - 2008
  • A Pilot Study Of 1h-Nuclear Magnetic Resonance Spectroscopic Imaging In PediatriNational Cancer Institute
    2007 - 2007
  • Convection Enhanced Delivery Of Agents Into The Brainstem Of Patients With DIFFNational Cancer Institute
    2007 - 2008
  • An Exploratory Study Of Biologic And Pathophysiologic Efects Of Radiation TherapNational Cancer Institute
    2007 - 2008
  • A Phase I Trial Of CC-5013 (LENALIDOMIDE) In Pediatric Patients With Recurrent ONational Cancer Institute
    2007 - 2008
  • Phase II Trial Of O6-Benzylguanine And Temozolomide In Pediatric Patients With HNational Cancer Institute
    2007 - 2007
  • Phase I Trial And Pharmacokinetic Study Of Temozolomide And O6-Benzylguanine InNational Cancer Institute
    2007 - 2007
  • Imaging Characteristics Of Diffuse Pontine Gliomas After Radiation TherapyNational Cancer Institute
    2007 - 2007
  • Evaluation Of The Natural History Of Patients With Tumors Of The Central NervousNational Cancer Institute
    2007 - 2007
  • Phase II Trial Of Peg-Intron In Children With Diffuse Pontine GliomasNational Cancer Institute
    2007 - 2008
  • A Comparative Study Of Pediatric CNS Tumor Activity As Assessed By18f-- FDG PETNational Cancer Institute
    2007 - 2007
  • 1h-Nuclear Magnetic Resonance Spectroscopic Imaging Of The Brain In Patients WHONational Cancer Institute
    2007 - 2007
  • An Exploratory Study Of Biologic And Pathophysiologic EFDivision Of Basic Sciences - Nci
    2006 - 2006
  • Evaluation Of The Natural History Of Patients With TumorDivision Of Basic Sciences - Nci
    2005 - 2006
  • Phase I Trial And Pharmacokinetic Study Of TemozolomideDivision Of Basic Sciences - Nci
    2005 - 2006
  • Imaging Characteristics Of Diffuse Pontine Gliomas AfterDivision Of Basic Sciences - Nci
    2005 - 2006
  • Phase II Trial Of O6-Benzylguanine And Temozolomide In PDivision Of Basic Sciences - Nci
    2005 - 2006
  • Phase II Trial Of Peg-Intron In Children With Diffuse PODivision Of Basic Sciences - Nci
    2005 - 2006
  • A Pilot Study Of 1h-Nuclear Magnetic Resonance SpectroscDivision Of Basic Sciences - Nci
    2005 - 2006
  • A Phase I Trial Of CC-5013 (LENALIDOMIDE) In Pediatric PDivision Of Basic Sciences - Nci
    2005 - 2006
  • A Comparative Study Of Pediatric CNS Tumor Activity As ADivision Of Basic Sciences - Nci
    2005 - 2006
  • 1h-Nuclear Magnetic Resonance Spectroscopic Imaging Of TDivision Of Basic Sciences - Nci
    2005 - 2006

Professional Memberships"

Alternate Names

  • Dr. Katherine Warren, Dr. Katherine Warren, MD, Dr. K Warren, Dr. Katherine Elizabeth Warren

Physicians, view Dr. Warren's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.HelpBlogCompanyContactPrivacyDirectory